This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

OGTT at Home Using CGM vs at the Clinic

Sponsored by Linkoeping University

About this trial

Last updated 2 months ago

Study ID

ogtt_cgm

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18 to 70 Years
All Sexes

Trial Timing

Started a year ago

What is this trial about?

This randomized, crossover study evaluates the feasibility and accuracy of a self-administered oral glucose tolerance test (OGTT) at home using continuous glucose monitoring (CGM) compared to a standard clinic-based OGTT. Participants with prediabetes will undergo both home-based and clinic-based OGTTs, with glucose levels measured via CGM and venous plasma glucose. The primary outcome is the correlation between CGM-based glucose values and standard OGTT results. Secondary outcomes include diagnostic agreement, metabolic hormone associations, and feasibility of home-based testing as a diagnostic tool for dysglycemia.

What are the participation requirements?

Inclusion Criteria

* Prediabetes indicated by ≥2 of the following values, measured at separate occasions or through different analyses during the past 2 years:

* - Fasting venous plasma glucose ≥6.1 but ≤6.9 mmol/L

* - Non-fasting venous plasma glucose ≥7.8 but ≤11.0 mmol/L

* - HbA1c ≥39 but ≤47 mmol/mol

* Access to a smart phone which is compatible with the CGM application and has working Bluetooth connectivity

* Ability to read and respond to online instructions and questionnaires in Swedish.

Exclusion Criteria

* T2D indicated by ≥2 of the following values, measured at different occasions or through different analyses:

* - Fasting venous plasma glucose ≥7.0 mmol/L

* - Non-fasting venous plasma glucose value ≥11.1 mmol/L

* - HbA1c ≥48 mmol/mol

* Previous bariatric surgery e.g., gastric by-pass or gastric sleeve surgery

* Body mass index <20 kg/m2

* Body weight <43 kg

* Current pregnancy

* Need of regular use of GLP-1 receptor agonists, SGLT-2 inhibitors, acetaminophen or ascorbic acid supplements during the study period

* Fear of needle sticks

* Shift work during the study period

* Involvement in the study design, data collection, analysis, or participant recruitment.